Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Semin Arthritis Rheum. 2010 Sep 9;40(6):501–511. doi: 10.1016/j.semarthrit.2010.07.001

Appendix 1.

Additional clinical characteristics of the study population

Number of Respondents Mean ± SD or n (%)
Weight (kg) (mean ± SD) 293 95.2 kg ± 22.1

Body Mass Index [BMI, n (%)] 293
BMI < 18.5 (Underweight) 2 (0.7%)
BMI 18.5–24.9 (Normal) 54 (18.4%)
BMI 25–29.9 (Overweight) 112 (38.2%)
BMI ≥ 30 (Obese) 125 (42.7%)

Employment [n (%)] 292
Full Time Employment 63 (21.6%)
Part Time Employment 28 (9.6%)
Unemployed/Other 54 (18.5%)
Retired 147 (50.3%)

Years Since MD Diagnosis of Gout
Mean ± SD 286 13.8 years ± 12.3
Median 286 10.0 years
Interquartile Range (IQR) 25%=4; 50%=10; 75%=23

Current Gout Medications [n (% Yes)] 194
Patients on Allopurinol Alone 102 (52.6%)
Patients on Colchicine Alone 36 (18.6%)
Patients on Both Allopruinol and Colchicine 57 (29.4%)

Time Since Most Recent Gout Attack 296
Less than 1 month 102 (34.5%)
Between 1 and 4 months 77 (26.0%)
Between 4 and 12 months 51 (17.2%)
Longer than 1 year 66 (22.3%)

Number of Joints Involved During an Attack (mean ± SD) 168 5.2± 6.4

Severity of Typical Gout Attack Pain (mean ±SD) 160 6.71 ± 2.57

Family History of Gout n (%)] 284 103 (36.3%)